Profile photo of Julian Adams, PhD, President and CEO of SU2C, and a recognized leader in cancer research and innovation.

Julian Adams, PhD

President and CEO

Executive Team

Dana Hirsch Lipman

General Counsel and Human Resources

Senior Team

Catherine Higgins, Ph.D., Senior Vice President of Scientific Program Management, known for her expertise in overseeing scientific research initiatives and program development.

Catherine Higgins, PhD

Science Programs

Jenny Kuntz, currently overseeing Operations for Stand Up To Cancer, responsible for managing organizational processes and initiatives.

Jenny Kuntz

Operations

Martin Quessenberry, specializing in Digital Transformation and Innovation, recognized for driving technology advancements and strategic improvements within SU2C

Martin S. Quessenberry

Digital Transformation & Innovation

Founders and Advisors

Katie Couric, a member of the SU2C Founders and Advisors Committee, contributing her expertise and influence to support cancer research initiatives.

Katie Couric

SU2C Founders and Advisors Committee

Sherry Lansing, a member of the SU2C Founders and Advisors Committee, known for her leadership and advocacy in advancing cancer research and awareness.

Sherry Lansing

SU2C Founders and Advisors Committee

Kathleen Lobb

SU2C Founders and Advisors Committee

Lisa Paulsen, a member of the SU2C Founders and Advisors Committee, known for her contributions to advancing cancer research and advocacy efforts.

Lisa Paulsen

SU2C Founders and Advisors Committee

Rusty Robertson, a member of the SU2C Founders and Advisors Committee, contributing her expertise and influence to support cancer research initiatives.

Rusty Robertson

SU2C Founders and Advisors Committee

Sue Schwartz, a member of the SU2C Founders and Advisors Committee, contributing her expertise and influence to support cancer research initiatives.

Sue Schwartz

SU2C Founders and Advisors Committee

Pamela Williams, a member of the SU2C Founders and Advisors Committee, contributing her expertise and influence to support cancer research initiatives.

Pamela Oas Williams

SU2C Founders and Advisors Committee

Ellen Ziffren, a member of the SU2C Founders and Advisors Committee, contributing her expertise and influence to support cancer research initiatives.

Ellen Ziffren

SU2C Founders and Advisors Committee

In Remembrance

Cancer affects us all. We’re proud to honor two incredible women whose dedication, passion and brilliance helped build Stand Up To Cancer into the organization it is today. Their legacy continues to inspire SU2C’s commitment to ending cancer as we know it.

In remembrance of Noreen Fraser whose dedication, passion and brilliance helped build Stand Up To Cancer into the organization it is today.

The Late Noreen Fraser

Co-Founder, SU2C

In remembrance of Laura Ziskin whose dedication, passion and brilliance helped build Stand Up To Cancer into the organization it is today.

The Late Laura Ziskin

Co-Founder, SU2C

Board of Directors

Sherry Lansing, a member of the SU2C Founders and Advisors Committee, known for her leadership and advocacy in advancing cancer research and awareness.

Sherry Lansing

Chair

Jeff Bader

Secretary

Peter Seymour

Treasurer

Russel Chew, Board of Directors (BOD) Member, recognized for his contributions to organizational leadership and strategic direction.

Russell Chew

BOD Member

Susan Desmond-Hellmann, M.D., M.P.H., Board of Directors (BOD) Member, known for her leadership in healthcare and her commitment to advancing cancer research.

Susan Desmond-Hellmann, MD, MPH

BOD Member

William (Bill) Nelson, M.D., Ph.D., Board of Directors (BOD) Member, recognized for his expertise in oncology and contributions to cancer research and treatment.

William (Bill) Nelson, MD

BOD Member

Phillip A. Sharp, Ph.D., Board of Directors (BOD) Member, known for his groundbreaking work in molecular biology and contributions to cancer research.

Phillip A. Sharp, PhD

BOD Member

Science Advisory Committee

Chaired by William G. Nelson, MD, PhD, DSc, SU2C’s Scientific Advisory Committee is comprised of highly accomplished researchers, physicians, and patient advocates.

William G. Nelson, MD, PhD, DSc

Chair

John D. Carpten, Ph.D., Vice Chair of the Scientific Advisory Committee, recognized for his expertise in cancer genomics and contributions to advancing cancer research.

John D. Carpten, PhD

Vice Chair

Arnold J. Levine, Ph.D., Vice Chair of the Scientific Advisory Committee, known for his pioneering research in cancer biology and significant contributions to the field.

Arnold J. Levine, PhD

Vice Chair

Scott A. Armstrong, MD, PhD

Senior Vice President for Drug Discovery, Dana-Farber Cancer Institute
Chief Research Strategy Officer, Dana-Farber Cancer Institute
David G. Nathan Distinguished Professor of Pediatrics, Harvard Medical School
Member, Stand Up To Cancer Scientific Advisory Committee
Boston, MA

Carlos L. Arteaga, MD

Lisa K. Simmons Distinguished Chair in Comprehensive Oncology
Director, UTSW Harold C. Simmons Cancer Center
Professor of Medicine
Associate Dean of Oncology Programs
Dallas, TX

Adrian Bot, MD, PhD

RA Ventures
Venture Partner
Member, Stand Up To Cancer Scientific Advisory Committee
Beverly Hills, CA

Jacqueline Y. Beale, MPA

National Ambassador, American Cancer Society Cancer Action Network
Founder, C2JB Consulting
Adjunct Professor, Bowie State University
Member, Stand Up To Cancer Scientific Advisory Committee
Glenn Dale, MD

Lisa Butterfield, PhD

Distinguished Scientist
Member, Stand Up To Cancer Scientific Advisory Committee
San Francisco, CA

Michael A. Caligiuri, MD

President
Deana and Steve Campbell Physician-in-Chief Distinguished Chair
City of Hope National Medical Center
Duarte, CA

Steven Carr, PhD

Senior Director of Proteomics and Institute Scientist
Broad Institute
Cambridge, MA

Jenny C. Chang, MD

Ernest Cockrell, Jr. Presidential Distinguished Chair at
Houston Methodist
Member, Stand Up To Cancer Scientific Advisory Committee
Houston, TX

Christina Curtis, PhD, MSc

RZ Cao Professor of Medicine, Genetics, and Biomedical Data Science
Senior Vice Chair of Research, Department of Medicine
Director of AI and Cancer Genomics Stanford University
Member, Stand Up To Cancer Scientific Advisory Committee Stanford, CA

Suzanne Dahlberg, PhD

Associate Professor of Pediatrics
Harvard Medical School
Boston Children’s Hospital
Boston, MA

Alan D. D’Andrea, MD

Director, Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute
Cambridge, MA

Luis A. Diaz, Jr., MD

Head
Division of Solid Tumor Oncology
Grayer Family Chair
Memorial Sloan Kettering Cancer Center
New York, NY

S. Gail Eckhardt, MD

Associate Dean of Experimental Therapeutics
Baylor College of Medicine
Associate Director of Translational Research
Dan L Duncan Comprehensive Cancer Center
Houston, TX

Michael Fischbach, PhD

Liu (Liao) Family Professor of Bioengineering Stanford University
Member, Stand Up To Cancer Scientific Advisory Committee
Stanford, CA

Richard B. Gaynor, MD

President of Research and Development
BioNTech
Cambridge, MA

Nancy F. Goodman, JD

Executive Director and Founder
Kids v Cancer
Washington, DC

James L. Gulley, MD, PhD

Co-Director, Center for lmmuno-Oncology, National Cancer Institute
Clinical Director, National Cancer Institute
Member, Stand Up To Cancer Scientific Advisory Committee
Bethesda, MD

Shawna Hudson, PhD

Professor, Vice Chair of Research, and Henry Rutgers Chair of Family Medicine and Community Health
Rutgers Robert Wood Johnson Medical School
Co-Chair, Stand Up To Cancer Health Disparities Committee

Trey Ideker, PhD

Director of the Big Data Institute, University of Oxford
Professor, Department of Medicine at UC San Diego
Member, Stand Up To Cancer Scientific Advisory Committee
San Diego, CA

David G. Kirsch, MD, PhD

Senior Scientist
Peter and Shelagh Godsoe Chair in Radiation Medicine
Princess Margaret Cancer Centre
Toronto, Ontario Canada

Guillermina (Gigi) Lozano, PhD

Chair, Department of Genetics, Division of Basic Science
University of Texas MD Anderson Cancer Center
Member, Stand Up To Cancer Scientific Advisory Committee
Member, Stand Up To Cancer Health Disparities Committee
Houston, TX

Tomas J. Philipson, PhD

Daniel Levin Professor of Public Policy Emeritus
The University of Chicago
Chicago, IL

Martin Pomper, MD, PhD

Professor and Chair of Radiology, University of Texas
Southwestern Medical Center
Member, Stand Up To Cancer Scientific Advisory Committee

Trevor Pugh, PhD

Professor in the University of Toronto Department of Medical Biophysics Senior Scientist at the Princess Margaret Cancer Centre Senior Investigator at the Ontario Institute for Cancer Research

Srikant “Sri” Ramaswami, MS, JD

Srikant (Sri) Ramaswami
Founder and Principal
Sri Spoke Communications LLC – SriSpoke.com

Lecia Sequist, MD, MPH

Landry Family Professor of Medicine, Harvard Medical School Director, Cancer Early Detection and Diagnostics Program, Mass General Brigham Cancer Institute
Member, Stand Up To Cancer Scientific Advisory Committee
Boston, MA

Laura K. Shawver, PhD

President and CEO, Birdseye Therapeutics
Member, Stand Up To Cancer Scientific Advisory Committee
San Diego, CA

Peter Sorger, PhD

Otto Krayer Professor
Department of Systems Biology
Head of the Harvard Program in Therapeutic Sciences – HiTS
Harvard Medical School
Cambridge, MA

David A. Tuveson, MD, PhD

Professor and Director
Cold Spring Harbor Laboratory Cancer Center
Cold Spring Harbor, NY

Emeritus Members

Elizabeth H. Blackburn, PhD

Professor Emerita
The University of California, San Francisco
San Francisco, CA

Lisa Diller, MD

Chief Medical Officer
Dana-Farber Cancer Institute/ Boston Children’s Cancer and Blood Disorders Center
Cambridge, MA

Judy Garber, MD, MRH

Chief, Division for Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Cambridge, MA

Laurie H. Glimcher, MD

President and CEO Emerita
Principal Investigator, Cancer Immunology and Virology
Richard and Susan Smith Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA

William N. Hait, MD, PhD

Global Head of External Innovation
Janssen, Pharmaceutical Companies
of Johnson & Johnson
Raritan, NJ

William G. Kaelin, Jr., MD

Sydney Farber Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA

Tak W. Mak, PhD

Chief Scientific Officer
Campbell Faily Institute
University of Toronto
Toronto, ON CANADA

Andre Nussenzweig, PhD

Chief, Laboratory of Genome Integrity
NIH Distinguished Investigator
Center for Cancer Research
National Cancer Institute
Bethesda, MD

Roderic I. Pettigrew, PhD, MD

CEO of engineering Health (enHealth) Robert A. Welch Professor and Executive Dean
School of Engineering Medicine Texas A&M University and Houston Methodist Hospital
Houston, TX

Cecil B. Pickett, PhD

President, R&D (retired)
Biogen Inc.
Sarasota, FL

Carol L. Prives, PhD

Da Costa Professor
Columbia University
New York, NY

Phillip A. Sharp, PhD

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Cambridge, MA

Arlene Sharpe, MD, PhD

George Fabyan Professor of Comparative Pathology
Co-Director, Harvard Institute of Translational Immunology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School
Boston, MA

SU2C Health Disparities Committee

John D. Carpten, PhD | Chair

Chief Scientific Officer
Irell & Manella Cancer Center
Director’s Distinguished Chair
Morgan & Helen Chu Director’s Chair
Beckman Research Institute
Professor, Integrative Translational Sciences
City of Hope
Duarte, CA

Andrew T. Chan, MD, MPH

Daniel K Podolsky Professor of Medicine
Harvard Medical School
Boston, MA

Margaret Foti, PhD, MD (H.C.)

Chief Executive Officer, American Association for Cancer Research
Stand Up To Cancer Health Disparities Committee
Philadelphia, PA

Shawna Hudson, PhD | Co-Chair

Professor and Research Division Chief,
Department of Family Medicine and Community Health
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ

Chanita Hughes-Halbert, PhD

Guillermina (Gigi) Lozano, PhD

Guillermina (Gigi) Lozano, PhD

Chairman and Professor
University of Texas MD Anderson Cancer Center
Houston, TX

David R. Wilson, PhD

Associate Vice President Health Research
Chair, Department of Indigenous Health
School of Medicine and Health Sciences
University of North Dakota
Grand Forks, ND

Robert A. Winn, MD

Cancer Center Director
Professor, Cancer Prevention and Control Program
Fox Chase Cancer Center
Senior Associate Dean for Cancer Research Innovation and Professor, Department of Cancer and Cellular Biology
Lewis Katz School of Medicine at Temple University

Clayton C. Yates, PhD

Johns Hopkins School of Medicine
John. R. Lewis Endowed Professor
Professor of Pathology, Oncology, and Urology
Director for Translational Health Disparities and Global Health Equity Research
Program Co-Leader for Cancer Genetics and Epigenetics
Sidney Kimmel Comprehensive Cancer Center

Emeritus Members

Karen Winkfield, MD, PhD

Executive Director
Meharry-Vanderbilt Alliance
Nashville, TN

Stand Up To Cancer conducts a highly involved review process to identify the top research proposals that have the potential to make a significant impact in the cancer space. The American Association for Cancer Research is SU2C’s scientific partner and supports the review of grants it administers on behalf of SU2C. This review process is conducted in collaboration with SU2C’s Scientific Advisory Committee.